BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 20439438)

  • 21. Capsaicin differentially modulates voltage-activated calcium channel currents in dorsal root ganglion neurones of rats.
    Hagenacker T; Splettstoesser F; Greffrath W; Treede RD; Büsselberg D
    Brain Res; 2005 Nov; 1062(1-2):74-85. PubMed ID: 16269136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons.
    Huang CS; Song JH; Nagata K; Yeh JZ; Narahashi T
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1280-90. PubMed ID: 9316836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of recombinant N-type and native high voltage-gated neuronal Ca2+ channels by AdGABA: mechanism of action studies.
    Martínez-Hernández E; Sandoval A; González-Ramírez R; Zoidis G; Felix R
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):270-7. PubMed ID: 21059371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain.
    Matthews EA; Bee LA; Stephens GJ; Dickenson AH
    Eur J Neurosci; 2007 Jun; 25(12):3561-9. PubMed ID: 17610575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loperamide blocks high-voltage-activated calcium channels and N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons.
    Church J; Fletcher EJ; Abdel-Hamid K; MacDonald JF
    Mol Pharmacol; 1994 Apr; 45(4):747-57. PubMed ID: 8183255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiamine suppresses thermal hyperalgesia, inhibits hyperexcitability, and lessens alterations of sodium currents in injured, dorsal root ganglion neurons in rats.
    Song XS; Huang ZJ; Song XJ
    Anesthesiology; 2009 Feb; 110(2):387-400. PubMed ID: 19194165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
    Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
    Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voltage-dependent calcium channels as targets for convulsant and anticonvulsant alkyl-substituted thiobutyrolactones.
    Gross RA; Covey DF; Ferrendelli JA
    J Pharmacol Exp Ther; 1997 Feb; 280(2):686-94. PubMed ID: 9023280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of potassium channels elicits calcium-dependent plateau potentials in suprachiasmatic neurons of the rat.
    Pierson PM; Liu X; Raggenbass M
    Brain Res; 2005 Mar; 1036(1-2):50-9. PubMed ID: 15725401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of voltage-dependent calcium currents by serotonin in acutely isolated rat amygdala neurons.
    Lin CH; Huang YC; Tsai JJ; Gean PW
    Synapse; 2001 Sep; 41(4):351-9. PubMed ID: 11494406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological and molecular evidence of L-(Cav1), N- (Cav2.2), and R- (Cav2.3) type Ca2+ channels in rat cortical astrocytes.
    D'Ascenzo M; Vairano M; Andreassi C; Navarra P; Azzena GB; Grassi C
    Glia; 2004 Mar; 45(4):354-63. PubMed ID: 14966867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain.
    Shao PP; Ye F; Chakravarty PK; Varughese DJ; Herrington JB; Dai G; Bugianesi RM; Haedo RJ; Swensen AM; Warren VA; Smith MM; Garcia ML; McManus OB; Lyons KA; Li X; Green M; Jochnowitz N; McGowan E; Mistry S; Sun SY; Abbadie C; Kaczorowski GJ; Duffy JL
    J Med Chem; 2012 Nov; 55(22):9847-55. PubMed ID: 23098566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
    Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
    J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional compensation by other voltage-gated Ca2+ channels in mouse basal forebrain neurons with Ca(V)2.1 mutations.
    Etheredge JA; Murchison D; Abbott LC; Griffith WH
    Brain Res; 2007 Apr; 1140():105-19. PubMed ID: 16364258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of recombinant Ca(v)3.1 (alpha(1G)) T-type calcium channels by the antipsychotic drug clozapine.
    Choi KH; Rhim H
    Eur J Pharmacol; 2010 Jan; 626(2-3):123-30. PubMed ID: 19782679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide.
    Todorovic SM; Jevtovic-Todorovic V; Mennerick S; Perez-Reyes E; Zorumski CF
    Mol Pharmacol; 2001 Sep; 60(3):603-10. PubMed ID: 11502893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct inhibition of Ih by analgesic loperamide in rat DRG neurons.
    Vasilyev DV; Shan Q; Lee Y; Mayer SC; Bowlby MR; Strassle BW; Kaftan EJ; Rogers KE; Dunlop J
    J Neurophysiol; 2007 May; 97(5):3713-21. PubMed ID: 17392420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of mirogabalin, a novel ligand for the α₂δ subunit of voltage-gated calcium channels, on N-type calcium channel currents of rat dorsal root ganglion culture neurons.
    Kitano Y; Wakimoto S; Tamura S; Kubota K; Domon Y; Arakawa N; Saito M; Sava B; Buisson B
    Pharmazie; 2019 Mar; 74(3):147-149. PubMed ID: 30961679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic insights into the analgesic efficacy of A-1264087, a novel neuronal Ca(2+) channel blocker that reduces nociception in rat preclinical pain models.
    Zhu CZ; Vortherms TA; Zhang M; Xu J; Swensen AM; Niforatos W; Neelands T; Milicic I; Lewis LG; Zhong C; Gauvin D; Mikusa J; Zhan C; Pai M; Roderwald V; Chu KL; Cole EE; Bespalov A; Searle XB; McGaraughty S; Bitner RS; Jarvis MF; Bannon AW; Joshi SK; Scott VE; Lee CH
    J Pain; 2014 Apr; 15(4):387.e1-14. PubMed ID: 24374196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A potent and selective indole N-type calcium channel (Ca(v)2.2) blocker for the treatment of pain.
    Tyagarajan S; Chakravarty PK; Park M; Zhou B; Herrington JB; Ratliff K; Bugianesi RM; Williams B; Haedo RJ; Swensen AM; Warren VA; Smith M; Garcia M; Kaczorowski GJ; McManus OB; Lyons KA; Li X; Madeira M; Karanam B; Green M; Forrest MJ; Abbadie C; McGowan E; Mistry S; Jochnowitz N; Duffy JL
    Bioorg Med Chem Lett; 2011 Jan; 21(2):869-73. PubMed ID: 21195616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.